214 related articles for article (PubMed ID: 33370315)
21. Impaired Refinement of Kinematic Variability in Huntington Disease Mice on an Automated Home Cage Forelimb Motor Task.
Woodard CL; Sepers MD; Raymond LA
J Neurosci; 2021 Oct; 41(41):8589-8602. PubMed ID: 34429377
[TBL] [Abstract][Full Text] [Related]
22. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Menalled LB; Sison JD; Dragatsis I; Zeitlin S; Chesselet MF
J Comp Neurol; 2003 Oct; 465(1):11-26. PubMed ID: 12926013
[TBL] [Abstract][Full Text] [Related]
23. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.
Dorner JL; Miller BR; Barton SJ; Brock TJ; Rebec GV
Behav Brain Res; 2007 Mar; 178(1):90-7. PubMed ID: 17239451
[TBL] [Abstract][Full Text] [Related]
24. Altered Aconitase 2 Activity in Huntington's Disease Peripheral Blood Cells and Mouse Model Striatum.
Chen CM; Wu YR; Chang KH
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160844
[TBL] [Abstract][Full Text] [Related]
25. The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease.
Beaumont V; Mrzljak L; Dijkman U; Freije R; Heins M; Rassoulpour A; Tombaugh G; Gelman S; Bradaia A; Steidl E; Gleyzes M; Heikkinen T; Lehtimäki K; Puoliväli J; Kontkanen O; Javier RM; Neagoe I; Deisemann H; Winkler D; Ebneth A; Khetarpal V; Toledo-Sherman L; Dominguez C; Park LC; Munoz-Sanjuan I
Exp Neurol; 2016 Aug; 282():99-118. PubMed ID: 27163548
[TBL] [Abstract][Full Text] [Related]
26. Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.
Sawiak SJ; Wood NI; Morton AJ
J Huntingtons Dis; 2016 Oct; 5(3):271-283. PubMed ID: 27662335
[TBL] [Abstract][Full Text] [Related]
27. The Q175 mouse model of Huntington's disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep.
Loh DH; Kudo T; Truong D; Wu Y; Colwell CS
PLoS One; 2013; 8(7):e69993. PubMed ID: 23936129
[TBL] [Abstract][Full Text] [Related]
28. Genetic deletion of S6k1 does not rescue the phenotypic deficits observed in the R6/2 mouse model of Huntington's disease.
Irvine EE; Katsouri L; Plattner F; Al-Qassab H; Al-Nackkash R; Bates GP; Withers DJ
Sci Rep; 2019 Nov; 9(1):16133. PubMed ID: 31695068
[TBL] [Abstract][Full Text] [Related]
29. Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease.
Ragauskas S; Leinonen H; Puranen J; Rönkkö S; Nymark S; Gurevicius K; Lipponen A; Kontkanen O; Puoliväli J; Tanila H; Kalesnykas G
PLoS One; 2014; 9(12):e113317. PubMed ID: 25469887
[TBL] [Abstract][Full Text] [Related]
30. Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease.
Smith GA; Rocha EM; McLean JR; Hayes MA; Izen SC; Isacson O; Hallett PJ
Hum Mol Genet; 2014 Sep; 23(17):4510-27. PubMed ID: 24728190
[TBL] [Abstract][Full Text] [Related]
31. Enhanced striatopallidal gamma-aminobutyric acid (GABA)
Perez-Rosello T; Gelman S; Tombaugh G; Cachope R; Beaumont V; Surmeier DJ
Mov Disord; 2019 May; 34(5):684-696. PubMed ID: 30726572
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease.
Fisher SP; Black SW; Schwartz MD; Wilk AJ; Chen TM; Lincoln WU; Liu HW; Kilduff TS; Morairty SR
Brain; 2013 Jul; 136(Pt 7):2159-72. PubMed ID: 23801738
[TBL] [Abstract][Full Text] [Related]
33. Cortical Network Dynamics Is Altered in Mouse Models of Huntington's Disease.
Donzis EJ; Estrada-Sánchez AM; Indersmitten T; Oikonomou K; Tran CH; Wang C; Latifi S; Golshani P; Cepeda C; Levine MS
Cereb Cortex; 2020 Apr; 30(4):2372-2388. PubMed ID: 31761935
[TBL] [Abstract][Full Text] [Related]
34. Alterations in Hippocampal Inhibitory Synaptic Transmission in the R6/2 Mouse Model of Huntington's Disease.
Dargaei Z; Liang X; Serranilla M; Santos J; Woodin MA
Neuroscience; 2019 Apr; 404():130-140. PubMed ID: 30797895
[TBL] [Abstract][Full Text] [Related]
35. Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease.
Anglada-Huguet M; Giralt A; Rué L; Alberch J; Xifró X
Biochim Biophys Acta; 2016 Jul; 1862(7):1255-66. PubMed ID: 27063456
[TBL] [Abstract][Full Text] [Related]
36. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
[TBL] [Abstract][Full Text] [Related]
37. Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington's disease transgenic R6/2 (160 CAG) mice.
Di Pardo A; Carrizzo A; Damato A; Castaldo S; Amico E; Capocci L; Ambrosio M; Pompeo F; De Sanctis C; Spinelli CC; Puca AA; Remondelli P; Maglione V; Vecchione C
Sci Rep; 2017 Feb; 7():42797. PubMed ID: 28211486
[TBL] [Abstract][Full Text] [Related]
38. Intravenous immunoglobulin ameliorates motor and cognitive deficits and neuropathology in R6/2 mouse model of Huntington's disease by decreasing mutant huntingtin protein level and normalizing NF-κB signaling pathway.
Liu SY; Yu XL; Zhu J; Liu XM; Zhang Y; Dong QX; Ma S; Liu RT
Brain Res; 2018 Oct; 1697():21-33. PubMed ID: 29902468
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Huntington's disease phenotype progression in male and female heterozygous FDNQ175 mice.
Li SH; Colson TL; Chen J; Abd-Elrahman KS; Ferguson SSG
Mol Brain; 2023 Sep; 16(1):67. PubMed ID: 37726802
[TBL] [Abstract][Full Text] [Related]
40. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models.
Menalled L; El-Khodor BF; Patry M; Suárez-Fariñas M; Orenstein SJ; Zahasky B; Leahy C; Wheeler V; Yang XW; MacDonald M; Morton AJ; Bates G; Leeds J; Park L; Howland D; Signer E; Tobin A; Brunner D
Neurobiol Dis; 2009 Sep; 35(3):319-36. PubMed ID: 19464370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
